Abstract Details
|
Ryotaro Ikeguchi
PRESENTER |
Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceutical Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharma K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma Corporation. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx Japan K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma GK. Ryotaro Ikeguchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma Corporation. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co., Ltd.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma K.K.. Ryotaro Ikeguchi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Japan Ltd.. |
| Yuko Shimizu, MD, PhD (Tokyo Women'S Medical University School of Medicine) | Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file |